Skip to main content
. 2001 Oct;104(2):127–134. doi: 10.1046/j.0019-2805.2001.01308.x

Table 1.

B-cell and total cell numbers in the bone marrow and spleen of IL-2−/− mice *

Source of cells

Cell subpopulation Age (weeks) IL-2−/− IL-2+/+
Bone marrow
 B220+/IgM  8–10 1·7 ± 1·1 4·1 ± 1·6
11–13 1·3 ± 0·6 4·4 ± 0·1
22–26 0·5 ± 0·1 3·7 ± 0·9
 Total cells  8–10 26·5 ± 8·9 19·4 ± 6·2
11–13 35·9 ± 13·2 21·8 ± 4·5
22–26 10·7 ± 3·9 20·2 ± 5·4
Spleen
 B220+  8–10 26·7 ± 11·3 57·7 ± 26·5
11–13  4·3 ± 2·3 46·7 ± 18·4
 Total cells  8–10 142·6 ± 54·0 105·9 ± 49·1
11–13 110·6 ± 2·3 100·0 ± 31·6
*

Bone marrow and spleen cells were collected from IL-2−/− and IL-2+/+ mice between the ages of 8 and 26 weeks. Cell subpopulations were identified by flow cytometry.

Number of mice per group. IL-2−/−: 8–10 weeks, n = 8; 11–13 weeks, n = 3; 22–26 weeks, n = 2. IL-2+/+: 8–10 weeks, n = 7; 11–13 weeks, n = 2; 22–26 weeks, n = 5.

Values represent the mean ± SD of the number of cells(×106) in each subpopulation determined by multiplying the % of bone marrow B220+/IgM cells (bone marrow gate includes lymphocytes and large granular cells) or splenic B220+ cells (spleen gate includes lymphocytes only) by the total number of cells obtained from bone marrow (femurs) or spleen of each animal.